Print Newsletter
Latest Photos
Latest News
30 Years Wiser & DCCT Trial Still Important to T1D
Posted May 2nd, 2013
In 1983, a trial began that would forever alter the standard of management of type 1 diabetes (T1D) and serve as a stepping stone to future research advances—and as we mark the 30th anniversary of the trial’s inception, we are still learning from the study.
Welcome to JDRF Capitol!
JDRF is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder and advocate of type 1 research. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is a disease which strikes children and adults suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications which may include kidney failure, blindness, heart disease, stroke, and amputation.
Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.6 billion to diabetes research, including more than $116 million in FY11. Currently, JDRF is funding 53 human clinical trials, several of which are in the advanced stages of clinical testing needed before FDA approvals are required.
The JDRF Capitol Chapter serves the Washington, DC metro area offering invaluable community outreach, support and education as well as a variety of events throughout the year to raise funds for diabetes research. Our region covers the District of Columbia; Charles, Montgomery, Prince George’s and St. Mary’s Counties in Maryland; Arlington, Fairfax, Loudoun, and Prince William Counties in Virginia; and Berkeley and Jefferson Counties in West Virginia.
